National Comprehensive Cancer Network

About NCCN

NCCN Publishes Updated Japanese Translations of Three NCCN Guidelines

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

The National Comprehensive Cancer Network® (NCCN®) recently posted updated Japanese translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2016; Prostate Cancer Early Detection, Version 2.2016; and Ovarian Cancer, Version 1.2016.

These recent translations are part of a larger endeavor by Translational Research Informatics (TRI) to translate the Complete Library of NCCN Guidelines® into non-adapted Japanese translations. Each translation of the NCCN Guidelines is managed by the appropriate medical society in Japan to ensure its accuracy for use by Japanese clinicians in the treatment of their patients.

Currently, there are 32 Japanese translations of NCCN Guidelines available on The addition of these translations further strengthens NCCN's commitment to improving the quality, effectiveness, and efficiency of cancer care regardless of language or geographic barriers.

If you would like to learn more about translating the NCCN Guidelines, please contact Jorge Bacigalupo,